Yinfeng Biotech joins hands with Changyu to advocate a healthy life
Release time:
2022-08-22
On the morning of August 22, Jiang Hua, deputy general manager of Changyu Group and general manager of brandy business department, and his party came to Yinfeng Biotechnology Park for a visit and exchange. Sheng Dewei, Vice President of Yinfeng Group and Chairman of Yinfeng Biological Group, Liu Xu, Vice President of Yinfeng Group and Chairman of Property Group, Wang Baoqing, President of Yinfeng Biological Group, Bai Xinjing, General Manager of Shandong Deren Economic and Trade Co., Ltd., and Han Zhen, General Manager of Shandong Qilu Cell Therapy Engineering Technology Co., Ltd., attended the event.

Jiang Hua and his entourage successively visited the "Infinite Life Plan" Science Museum and the "Life Extension Plan" exhibition hall to learn more about the storage and application prospects of cells in 5G scenarios, the application of cryogenic medicine, the first case of human cryopreservation in Asia, and the application of cryogenic medicine in organ transplantation and clinical practice.


During the discussion, the two sides explained the basic situation of the development of various enterprises, and conducted detailed communication on the development of the big health industry, hoping to strengthen enterprise exchanges and cooperation, seek cross-border opportunities, achieve win-win cooperation, and jointly advocate a healthy life.
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.